J E Poole

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. ncbi Low-energy impedance-compensating biphasic waveforms terminate ventricular fibrillation at high rates in victims of out-of-hospital cardiac arrest. LIFE Investigators
    J E Poole
    The University of Washington, Seattle 98195, USA
    J Cardiovasc Electrophysiol 8:1373-85. 1997
  2. ncbi Prognostic importance of defibrillator shocks in patients with heart failure
    Jeanne E Poole
    Division of Cardiology, University of Washington School of Medicine, 1959 NE Pacific St, Box 356422, Seattle, WA 98195 6422, USA
    N Engl J Med 359:1009-17. 2008
  3. ncbi Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry
    Jeanne E Poole
    University of Washington, Division of Cardiology, 1959 NE Pacific Street, Seattle, WA 98198 6422, USA
    Circulation 122:1553-61. 2010
  4. ncbi New indications for implantable defibrillator therapy
    Jeanne E Poole
    University of Washington School of Medicine, Division of Cardiology, Box 356422, 1959 NE Pacific Street, Seattle, WA 98195 6422, USA
    Curr Cardiol Rep 8:330-5. 2006
  5. ncbi Treatment of out-of-hospital cardiac arrest with a low-energy impedance-compensating biphasic waveform automatic external defibrillator. The LIFE Investigators
    B E Gliner
    Heartstream, Inc, Seattle, WA 98121, USA
    Biomed Instrum Technol 32:631-44. 1998
  6. ncbi Home use of automated external defibrillators for sudden cardiac arrest
    Gust H Bardy
    Seattle Institute for Cardiac Research, Seattle, WA 98103 4819, USA
    N Engl J Med 358:1793-804. 2008
  7. ncbi Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
    Daniel B Mark
    Outcomes Research Group, Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
    Circulation 114:135-42. 2006
  8. ncbi No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)
    Joseph A Blatt
    Department of Cardiology, University of Washington, Box 356422, 1959 NE Pacific Street, Seattle, Washington 98195, USA
    J Am Coll Cardiol 52:551-6. 2008
  9. ncbi Not the usual cardiac rhythm device infection: a fastidious pathogen with several teaching points
    Peter J Cawley
    Division of Cardiology, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195 6422, USA
    J Hosp Med 3:173-5. 2008
  10. ncbi Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study
    Brian Olshansky
    University of Iowa, Iowa City, Iowa, USA
    J Am Coll Cardiol 51:1277-82. 2008

Detail Information

Publications18

  1. ncbi Low-energy impedance-compensating biphasic waveforms terminate ventricular fibrillation at high rates in victims of out-of-hospital cardiac arrest. LIFE Investigators
    J E Poole
    The University of Washington, Seattle 98195, USA
    J Cardiovasc Electrophysiol 8:1373-85. 1997
    ..The objective of this study was to observe the performance of a low-energy impedance-compensating biphasic waveform in the out-of-hospital setting on 100 consecutive victims of sudden cardiac arrest...
  2. ncbi Prognostic importance of defibrillator shocks in patients with heart failure
    Jeanne E Poole
    Division of Cardiology, University of Washington School of Medicine, 1959 NE Pacific St, Box 356422, Seattle, WA 98195 6422, USA
    N Engl J Med 359:1009-17. 2008
    ..e., prevention of a first life-threatening arrhythmic event) may later receive therapeutic shocks from the ICD. Information about long-term prognosis after ICD therapy in such patients is limited...
  3. ncbi Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry
    Jeanne E Poole
    University of Washington, Division of Cardiology, 1959 NE Pacific Street, Seattle, WA 98198 6422, USA
    Circulation 122:1553-61. 2010
    ..These procedures are generally considered low risk despite results from recent retrospective series reporting higher rates...
  4. ncbi New indications for implantable defibrillator therapy
    Jeanne E Poole
    University of Washington School of Medicine, Division of Cardiology, Box 356422, 1959 NE Pacific Street, Seattle, WA 98195 6422, USA
    Curr Cardiol Rep 8:330-5. 2006
    ....
  5. ncbi Treatment of out-of-hospital cardiac arrest with a low-energy impedance-compensating biphasic waveform automatic external defibrillator. The LIFE Investigators
    B E Gliner
    Heartstream, Inc, Seattle, WA 98121, USA
    Biomed Instrum Technol 32:631-44. 1998
    ..Use of this waveform allows AED device characteristics consistent with widespread AED deployment and early defibrillation...
  6. ncbi Home use of automated external defibrillators for sudden cardiac arrest
    Gust H Bardy
    Seattle Institute for Cardiac Research, Seattle, WA 98103 4819, USA
    N Engl J Med 358:1793-804. 2008
    ..Consequently, home use of an automated external defibrillator (AED) might offer an opportunity to improve survival for patients at risk...
  7. ncbi Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
    Daniel B Mark
    Outcomes Research Group, Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
    Circulation 114:135-42. 2006
    ..We examined long-term economic implications of these results...
  8. ncbi No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)
    Joseph A Blatt
    Department of Cardiology, University of Washington, Box 356422, 1959 NE Pacific Street, Seattle, Washington 98195, USA
    J Am Coll Cardiol 52:551-6. 2008
    ..This study investigated whether defibrillation threshold (DFT) testing during implantable cardioverter-defibrillator (ICD) implantation predicts clinical outcomes...
  9. ncbi Not the usual cardiac rhythm device infection: a fastidious pathogen with several teaching points
    Peter J Cawley
    Division of Cardiology, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195 6422, USA
    J Hosp Med 3:173-5. 2008
    ..Two large retrospective studies suggest that prolonged incubation for fastidious organisms is generally not necessary because of advances in culture media and automated blood culture systems...
  10. ncbi Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study
    Brian Olshansky
    University of Iowa, Iowa City, Iowa, USA
    J Am Coll Cardiol 51:1277-82. 2008
    ..The outcome of congestive heart failure (CHF) patients with syncope is understood incompletely...
  11. ncbi Evidence for pre- to postsynaptic mismatch of the cardiac sympathetic nervous system in ischemic congestive heart failure
    James H Caldwell
    Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington 98195, USA
    J Nucl Med 49:234-41. 2008
    ..Pre- and postsynaptic cardiac sympathetic function is altered in ischemic congestive heart failure (CHF). Whether there is a presynaptic-to-postsynaptic mismatch or whether mismatch is related to adverse cardiac events is unknown...
  12. ncbi PET measures of pre- and post-synaptic cardiac beta adrenergic function
    Jeanne M Link
    Department of Radiology, Box 356004, University of Washington, Seattle, WA 98195, USA
    Nucl Med Biol 30:795-803. 2003
    ..This imaging technique can help us understand regional sympathetic function in cardiac disease...
  13. ncbi Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
    Brian Olshansky
    Department of Internal Medicine, University of Iowa Hospitals, 4426A JCP, 200 Hawkins Dr, Iowa City, IA 52242, USA
    Am Heart J 153:1089-94. 2007
    ..In the SCD-HeFT, mortality of patients with CHF was assessed after randomization to an implantable cardioverter/defibrillator (ICD), amiodarone, or placebo. The aim of this study was to evaluate the location of deaths in SCD-HeFT...
  14. ncbi Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure
    Gust H Bardy
    Seattle Institute for Cardiac Research, Seattle, WA 98103, USA
    N Engl J Med 352:225-37. 2005
    ..Treatment with amiodarone or an implantable cardioverter-defibrillator (ICD) has been proposed to improve the prognosis in such patients...
  15. ncbi Rationale and design of the Home Automatic External Defibrillator Trial (HAT)
    Gust H Bardy
    The Seattle Institute for Cardiac Research, Seattle, WA 98103 4819, USA
    Am Heart J 155:445-54. 2008
    ..The results of the trial should be available in mid 2008...
  16. ncbi Absence of bilateral vision loss from amiodarone: a randomized trial
    Joel S Mindel
    Department of Ophthalmology, Mount Sinai School of Medicine, New York, NY 10029, USA
    Am Heart J 153:837-42. 2007
    ..The object of this study was to determine the incidence, dose, and time until onset of bilateral vision loss from amiodarone as a secondary end point in an investigation of amiodarone's role in preventing sudden death...
  17. ncbi Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
    Michael G Dickinson
    Thoracic Cardiovascular Institute Foundation, Lansing, MI, USA
    Am Heart J 153:573-8. 2007
    ..The study length, size, and degree of background HF, including the use of implantable defibrillator therapy, provide a unique opportunity to evaluate the impact of statin use in HF with mechanistic insights from subgroup analyses...
  18. ncbi Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
    Judith E Mitchell
    State University of New York Downstate Medical Center, Brooklyn, NY 11203, USA
    Am Heart J 155:501-6. 2008
    ..The purpose of this report is to describe the outcomes in African Americans (AAs) and other minorities...